Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.



Replimune Raises $55 Million To Advance Its Oncolytic Immunotherapy Programs

Biotechnology company focused on developing next generation oncolytic immunotherapies, announced today the completion of a $55 million Series B financing.

Read the rest of entry »

Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases

$40 million investment to accelerate development of Immunocore’s ImmTAV® and ImmTAB® therapeutics for infectious diseases, in particular tuberculosis and HIV

Read the rest of entry »

AMSBIO has announced a new range of CD47-relevant products suitable for rapid high throughput screening studies.

 The new AMSBIO CD47 protein kits are supplied as pairs of products that can be easily adapted to ELISA, AlphaLISA™ and MSD platforms to facilitate rapid and easy screening of the neutralizing compound.

Read the rest of entry »

Wireless technology breathes new life into medical practices

A leading clinician of a top UK children’s hospital believes wireless monitoring is changing the face of healthcare.

Read the rest of entry »

Invicro Acquires Imanova to Expand Global Imaging Capabilities

Combined business delivers world-leading imaging capabilities to drive improved decision-making from early drug discovery to late-phase clinical development

Read the rest of entry »

Wickham Labs to Exhibit at Medtec Ireland 2017

Wickham Laboratories Ltd is pleased to announce that we will be on stand 305 at the upcoming Medtec Ireland, held on 4-5 October 2017 at the Radisson Blu Hotel in Galway, Ireland.

Read the rest of entry »

Speculative 110,000 sq ft office and laboratory Development reaches key milestone on at Milton Park, Oxfordshire

Construction work at the £24m Park Drive East development at Milton Park being undertaken by MEPC has reached the half way milestone

Read the rest of entry »

Novartis gene therapy approval signals new cancer treatment era

Novartis AG won highly anticipated U.S. approval for the first of a new type of potent gene-modifying immunotherapy for leukemia, a $475,000 treatment that marks the start of a potential new treatment paradigm for some cancers.

Read the rest of entry »

Gilead buys into CAR-T with $11.9bn deal for Kite

Gilead Sciences is buying Kite Pharma in a deal worth $11.9 billion, securing itself access to the latter’s experimental CAR-T therapy axicabtagene ciloleucel and wider cancer pipeline.

Read the rest of entry »

The Midlands Engine Investment Fund (MEIF) Debt Funds (including Small Business Loans) were officially launched in August 2017, with further Equity Funds being released in due course.

The Midlands Engine Investment Fund aims to boost the region’s economy and supporting the growth ambitions of the 780,000 smaller businesses within the region. It is part funded by the European Regional Development Fund.

Read the rest of entry »

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.

OBN Noticeboard

This is an impromptu noticeboard to let people know about events, other things that are happening, perhaps lab equipment for sale etc.  Just drop an email to us, team@obn.org.uk, and we will post.